S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TNFA TNF Pharmaceuticals Inc

0.5991

0.00 (0.00%)

Feb 06 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

TNF Pharmaceuticals (NASDAQ:TNFA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more TNF Pharmaceuticals Charts.

TNF Pharmaceuticals (NASDAQ:TNFA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more TNF Pharmaceuticals Charts.

TNF Pharmaceuticals Inc News

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
Wednesday 29 January 2025 (1 week ago) • Business Wire

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
Wednesday 15 January 2025 (3 weeks ago) • Business Wire

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
Thursday 19 December 2024 (2 months ago) • Business Wire

Premarket Action Is Heating Up For This Biotech
Tuesday 10 December 2024 (2 months ago) • AllPennyStocks.com

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
Monday 9 December 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Tuesday 26 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Friday 1 November 2024 (3 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Friday 1 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 4 October 2024 (4 months ago) • Edgar (US Regulatory)

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
Wednesday 2 October 2024 (4 months ago) • Business Wire

More TNF Pharmaceuticals Inc News Articles

Bell Buckle (PK)

Health Advance (PK)

MineralRite (PK)

Decentral Life (PK)

Fannie Mae (QB)

TheGlobe com (PK)

Hannover House (PK)

Tonix Pharmaceuticals

Voip Pal Com (QB)

Adia Nutrition (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions